UPDATE - ICAD to Report First Quarter 2024 Financial Results on May 15, 2024
Call Time is 8:30 AM Eastern TimeNASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today
ICAD to Report First Quarter 2024 Financial Results on May 15, 2024
NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial result
ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. (NASDAQ: ICAD) announced today it will showcase its ProFound Breast Health Suite of AI solutions, including the newly released ProFound Cloud, powered by Google Cloud and Google Health AI architecture, while also highlighting its recently announced partnership with Densitas, a global leader in AI solutions for breast cancer screening, at the Society for Breast Imaging (SBI) annual symposium, April 11-14 in Montreal, Canada.
Express News | ICAD And Densitas Partner To Enhance Precision Breast Health With Leading AI Solutions
ICAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
iCAD, Inc. (NASDAQ: ICAD) announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels.
Express News | ICad Shares Are Trading Higher After the Company Announced a Collaboration With Rad-AID to Introduce Mammography AI-based Decision Support in LMICs
Express News | ICAD Partners With RAD-AID To Advance Breast Cancer Detection Using AI In Underserved Regions
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
NASHUA, N.H., April 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced commercial availability of ProFound Cloud. The
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
Newly released capabilities -- limiting the number of marks on a 3D view, color-coding lesion marks, and color-coding the ProFound Scorecard -- enhance radiologists' interpretability and efficiencyNAS
Earnings Call Summary | ICAD Inc(ICAD.US) Q4 2023 Earnings Conference
The following is a summary of the ICAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript:Financial Performance:iCAD reported annual revenue of $17.3 million in 2023, a decrease of 13% compared to 2022, du
Icad: Q4 Earnings Insights
icad (NASDAQ:ICAD) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:01 PM.Here's what investors need to know about the announcement.Earningsicad beat estimated earnings by 60.0%, repo
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, Vs. Street Est of $4.3M
04:03 PM EDT, 03/12/2024 (MT Newswires) -- Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M
ICAD Non-GAAP EPS of -$0.02 Beats by $0.03, Revenue of $4.74M Beats by $0.46M
ICAD 4Q Rev $4.74M >ICAD
ICAD 4Q Rev $4.74M >ICAD
Press Release: ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. (
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. • MINISO Group Holding (NYSE:MNSO) is likely to report quarterly earnings at $0.27
Notable Earnings After Tuesday's Close
ICAD Q4 2023 Earnings Preview
Earnings Outlook For Icad
icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here's what investors need to know before the announcement.Analysts estimate that icad will report an ear
Investors in ICAD (NASDAQ:ICAD) From Three Years Ago Are Still Down 87%, Even After 44% Gain This Past Week
No Data